Hong Kong Pharma Digital Technology Holdings LTD Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NASDAQ
SCHEDULE 13G: Atlantic Health Century International Group Discloses 5.62% Stake in Hong Kong Pharma Digital Technology Holdings Ltd
Atlantic Health Century International Group has reported a beneficial ownership of 5.62% in Hong Kong Pharma Digital Technology Holdings Ltd, holding 617,850 ordinary shares as of March 31, 2025.
NASDAQ
SCHEDULE 13G: Pacific Health Century International Group Discloses 5.62% Stake in Hong Kong Pharma Digital Technology Holdings Ltd
Pacific Health Century International Group has filed a Schedule 13G, disclosing beneficial ownership of 5.62% of Hong Kong Pharma Digital Technology Holdings Ltd's Ordinary Shares as of March 31, 2025.
NASDAQ
SCHEDULE 13G: Major Shareholder Discloses Over 56% Stake in Hong Kong Pharma Digital Technology Holdings
Lap Sun Wong and affiliated entities have disclosed beneficial ownership of 56.77% of Hong Kong Pharma Digital Technology Holdings Limited's Ordinary Shares.